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Mutations in the filament aggregating protein (filaggrin) gene have recently been identified as the cause of the
common genetic skin disorder ichthyosis vulgaris (IV), the most prevalent inherited disorder of keratinization.
The main characteristics of IV are fine-scale on the arms and legs, palmar hyperlinearity, and keratosis pilaris.
Here, we have studied six Irish families with IV for mutations in filaggrin. We have identified a new mutation,
3702delG, in addition to further instances of the reported mutations R501X and 2282del4, which are common in
people of European origin. A case of a 2282del4 homozygote was also identified. Mutation 3702delG terminates
protein translation in filaggrin repeat domain 3, whereas both recurrent mutations occur in repeat 1. These
mutations are semidominant: heterozygotes have an intermediate phenotype most readily identified by palmar
hyperlinearity and in some cases fine-scale and/or keratosis pilaris, whereas homozygotes or compound
heterozygotes generally have more marked ichthyosis. Interestingly, the phenotypes of individuals homozygous
for R501X, 2282del4, or compound heterozygous for R501X and 3702delG, were comparable, suggesting that
mutations located centrally in the filaggrin repeats are also pathogenic.
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INTRODUCTION
Ichthyosis vulgaris (IV; OMIM#146700) is a common genetic
skin disorder that occurs worldwide and affects all races
(Irvine and Paller, 2002; Judge et al., 2004). Clinically, it
presents within the first few months or years of life with
scaling of the skin that is generally most pronounced on the
extensor surfaces. Palmar and plantar hyperlinearity is often a
feature. Keratosis pilaris and, importantly, atopic dermatitis
(AD) are commonly seen in IV (Mevorah et al., 1985).
Histologically, keratohyalin granules can be absent or
reduced in the epidermis of IV patients (Compton et al.,
2002; Fleckman and Brumbaugh, 2002). The inheritance of
IV has been described as autosomal dominant with variable
penetrance (Judge et al., 2004). However, with the recent
identification of mutations in the filament aggregating protein
(filaggrin) gene as the cause of IV, it has become apparent
that the disease is inherited as a semidominant trait, that is,
homozygotes have a severe phenotype, and heterozygotes
have a mild phenotype (Smith et al., 2006).
The main function of filaggrin is formation of the stratum
corneum during epidermal differentiation (Steinert et al., 1981;
Dale et al., 1985; Listwan and Rothnagel, 2004). The highly
phosphorylated 400 kDa polyprotein profilaggrin is synthesized
in the granular layer and makes up a major component of
keratohyalin granules. Profilaggrin consists of a short unique
N-terminal calcium-binding domain, followed by 10–12 repeats
of the 324-amino-acid filaggrin sequence. These repeat
sequences are separated by short linker peptides. Profilaggrin
is the inactive precursor of filaggrin, but when granular cells
undergo terminal differentiation, profilaggrin is dephosphory-
lated and proteolytically cleaved into B37 kDa filaggrin pep-
tides. These rapidly aggregate the keratin cytoskeleton, causing
the collapse of the granular cells into flattened squames. This
collapsed cytoskeleton, together with its attachment proteins
and membrane components, undergoes extensive crosslinking
to form the cornified cell envelope. The main function of the
cornified cell envelope is to form the outermost barrier layer of
the skin, which prevents water loss and keeps out allergens and
infectious agents (Candi et al., 2005).
The human profilaggrin gene (FLG) is located on chromo-
some 1q21 within a cluster of genes that make up the
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epidermal differentiation complex. Profilaggrin consists of
three exons (Presland et al., 1992); exon 1 (15 bp) contains
only 50-untranslated region sequences and the start codon is
within exon 2 (159 bp). Exon 3 is unusually large (12,753 bp)
and codes for most of the N-terminal domain and all the
filaggrin repeats. The high homology between the repeats at
the DNA level makes it difficult to perform conventional
PCR-based sequencing for the internal 10 kb or more of this
exon for mutation analysis.
A genome-wide linkage analysis study in a large American
family with IV showed segregation of the disorder to the
filaggrin locus on chromosome 1 (Compton et al., 2002).
A similar study in Chinese kindreds was suggestive of linkage
to this locus (Zhong et al., 2003). Very recently, we reported
mutations in filaggrin in that kindred and an additional 14
families with IV (Smith et al., 2006). We went on to show by
means of genetic linkage in IV families, two separate association
studies and a prospective study, that filaggrin mutations are a
major genetic factor in AD (Palmer et al., 2006). Here, we
studied six Irish families with IV, some of whom also have AD
and have identified further filaggrin defects.
RESULTS
Case reports
All probands in our cohort were referred to a pediatric
dermatologist with problematic dry skin on a background
history of AD. The clinical phenotype consisted of variable
fine semiadherent scaling, palmoplantar hyperlinearity, and
keratosis pilaris (Figure 1a and b). The scale was most
pronounced on the trunk and extensor surfaces of the arms
and lower legs, with relative sparing of the flexural creases,
and typically became more prominent during winter months.
Marked palmoplantar hyperlinearity was evident in all
probands, with a more subtle increase appreciable in siblings
and parents. A clinical designation of severe or mild IV was
made in all individuals based on severity of palmar
hyperlinearity and degree of dry skin and scaling (Figure 2).
We did not develop a formal scoring system for IV severity;
however, ‘‘severe IV’’ was recorded when there was marked
scaling and pronounced hyperlinearity (Figure 1a and b).
‘‘Mild IV’’ was recorded when there was mild scaling present
and when hyperlinearity was not marked compared to age-
matched controls, as scored by experienced dermatologists.
Keratosis pilaris was appreciable in six of the seven severely
affected individuals examined, with variable expression in
other family members. Where a history was available, the
inheritance pattern in these families, taking into account the
mild versus severe phenotype, was semidominant (Figure 2,
pedigrees). The filaggrin genotypes determined, below,
confirmed this inheritance pattern, which was recently
established (Smith et al., 2006). In addition, some affected
individuals in Families 2 and 4 (Figure 2) described seasonal
peeling of the distal fingers (not shown).
Novel and ancestral filaggrin mutations
The six Irish IV families presenting with IV were screened for
mutations within the filaggrin gene (FLG). Initially, families
were screened for the recently reported common filaggrin
mutations R501X and 2282del4 by restriction enzyme
digestion and confirmed independently by DNA sequencing.
In Family 1, the proband had the full, more marked IV
phenotype and was heterozygous for R501X, which was
found to be the paternal mutation. However, both the
proband and mother were both wild type for mutation
2282del4, despite the mother having the mild IV phenotype
and the proband having the severe phenotype consistent with
homozygous or compound heterozygous mutations. Thus,
further sequencing of the filaggrin gene was carried out,
a
b
c
Figure 1. Clinical features of ichthyosis vulgaris. (a) Fine scaling clearly
visible on the neck of the proband in Family 1 (arrows), who is compound
heterozygous for loss-of-function mutations in the filaggrin gene. (b) Marked
palmar hyperlinearity (arrows) seen here in the proband of Family 1. (c) Acral
peeling of the palmar surface of the fingertips was observed in two of the
families analyzed here (arrows). Despite this co-incidental finding in
unrelated IV families with confirmed FLG defects, this phenotype did not fully
co-segregate with filaggrin mutations. Specifically, individual II-4 in Family 3
was wild type for the three known FLG mutations but had the peeling fingertip
phenotype (see Figure 2).
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which led to the identification of a novel mutation,
3702delG, in the third filaggrin repeat domain encoded by
exon 3 (Figure 3). The proband was therefore compound
heterozygous for R501X/3702delG and the mother hetero-
zygous for 3702delG, consistent with the semidominant
inheritance pattern. A clinically unaffected sibling was wild
type for both mutations. A total of 183 Irish control DNA
samples were screened for mutation 3702delG by sizing of
fluorescent-labelled PCR fragments (Figure 3). All control
samples were wild type for 3702delG and 195 Scottish
population controls also lacked this mutation. These results
indicate that this is a rare mutation in contrast to the
previously reported mutations, R501X and 2282del4, which
are carried by 5.8% (n¼1250) and 3.4% (n¼1265),
respectively, of individuals in the Scottish/Irish population
(Palmer et al., 2006). As this was a pediatric case of IV, it was
not ethical to obtain biopsy material for immunohistochemi-
cal or biochemical analysis of the truncated proteins present
in this patient.
In Family 2, the severely affected proband was homo-
zygous for 2282del4 and her mildly affected brother was
heterozygous for 2282del4. Both parents were heterozygous
for 2282del4. This is the first reported case of a 2282del4
homozygote (Figure 3). In three further families (Families
3–5), the more severely affected individuals (Figure 2) were
all compound heterozygous for R501X and 2282del4. The
proband from Family 6 was homozygous for R501X and no
other family members were available for screening.
In two of these IV families, some individuals had peeling
of the ventral surface of the fingertips (Figure 1c). We recently
showed that loss-of-function missense mutations in the TGM5
gene encoding tranglutaminase 5, a crosslinking enzyme
expressed late in epidermal differentiation, cause a form of
acral peeling skin syndrome (Cassidy et al., 2005). Owing to
some overlap in phenotype and the co-expression of this
enzyme with filaggrin in the upper granular layer, we
screened these individuals for TGM5 mutations but no
potentially pathogenic changes were identified (data not
shown). In addition, one individual with the peeling finger-
tip phenotype did not have clinical features of IV and
lacked filaggrin mutations R501X, 2282del4, and 3702delG
(Figure 2). Thus, this appears to be a separate disorder, which
does not co-segregate with either IV or filaggrin defects,
despite the fact that it seems co-incidental that it should occur
in two unrelated IV families with confirmed IV-causing
filaggrin defects.
A number of individuals in the families studied here had
AD in addition to IV (Figure 2). Genetic linkage analysis
between AD and the FLG null alleles in these six kindreds
gave a maximum two-point lod score (Zmax) for AD¼0.69,
with no recombination observed (y¼0). Adding this to the
previous reported linkage data in nine IV/AD families (Palmer
et al., 2006) gives a cumulative lod score for AD of
Zmax¼3.96 at y¼0, almost one log10 over the accepted
significance level of 3.0.
DISCUSSION
Here, we have identified mutations in the filaggrin gene in a
further six Irish families with IV. In all cases, the semidomi-
nant inheritance pattern was confirmed by identification of a
single heterozygous loss-of-function filaggrin mutation in all
mildly affected individuals and two such mutations, either in
the homozygous or compound heterozygous state, in all
individuals showing the full, marked IV presentation.
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Figure 2. Pedigrees of ichthyosis vulgaris families studied. Family trees of the ichthyosis vulgaris families studied, all of which are of Irish ethnicity, showing
semidominant inheritance, that is, a subtle phenotype in heterozygotes and a more marked phenotype in homozygotes or compound heterozygotes. Filled
symbols denote the full, marked presentation of ichthyosis vulgaris; hatched symbols represent the milder presentation. Filaggrin genotypes are shown for the
individuals from whom DNA was obtained for analysis. AD, dermatologist-confirmed atopic dermatitis; PFT, dermatologist-confirmed peeling fingertip
phenotype.
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Importantly, in one case (Family 1) the severe IV phenotype
in the proband predicted the existence of a further novel
filaggrin mutation in addition to the common R501X and
2282del4 mutations. This molecular genetic prediction,
based on clinical observation, was indeed confirmed by the
identification of the third filaggrin mutation to be identified,
3702delG. The proband in Family 1 was compound
heterozygous for R501X and 3702delG, and the mildly
affected mother was a carrier of 3702delG alone. The new
mutation, 3702delG, was excluded from B400 controls of
Scottish/Irish ethnicity, showing that this is not common in
the population. This again confirms our semidominant model
of IV inheritance (Smith et al., 2006), in the context of a rare
combination of filaggrin genotypes.
Profilaggrin consists of 10 or more tandemly repeated
copies of the functional end-product of the gene, the 37 kDa
filaggrin repeat peptide (Steinert et al., 1981; Gan et al.,
1990). The 3702delG mutation is predicted to lead to
termination of profilaggrin translation within the third
filaggrin repeat domain. As the first two identified mutations,
R501X and 2282del4, both occur within filaggrin repeat 1
(Smith et al., 2006), it seemed possible that only this class of
mutation, leading to complete absence of filaggrin, would be
identified in IV and that mutations allowing expression of
even one or two repeats might not be pathogenic. However,
we see here in this compound heterozygote in Family 1 that
truncating mutations at least as far downstream as repeat 3
produce a severe IV phenotype clinically indistinguishable
from that arising from repeat 1 mutations. Analysis of further
severe IV patients lacking one of the common mutations,
such as Family 1 here, or even lacking either R501X or
2282del4, will shed further light on the full spectrum of
pathogenic mutations occurring in filaggrin and their
resultant functional and phenotypic consequences. It is
interesting to note that all three reported FLG mutations lead
to the expression of a residual N-terminal fragment of
profilaggrin, containing the S100-like calcium-binding do-
main. Previous studies using expression constructs have
shown that an analogous fragment of profilaggrin is stable
and following proteolytic processing is localized to a number
of subcellular compartments, including the nucleus (Presland
et al., 1997; Ishida-Yamamoto et al., 1998; Pearton et al.,
2002). Whether or not this is relevant to the pathogenesis of
IV and/or AD remains unclear.
The molecular genetic defect in the mouse model of IV,
flaky tail, has not yet been identified but detailed biochemical
data points to an internal truncating mutation in the vicinity
of repeats 6–7 of the murine FLG gene (Presland et al., 2000).
Interestingly, this truncated mutant profilaggrin in flaky tail is
not proteolytically processed into filaggrin despite the
presence of 6–7 repeats, presumably with all the required
cleavage sequences present (Presland et al., 2000). This
strongly implies that sequences close to the C-terminus of
profilaggrin are a prerequisite for filaggrin processing and so
one would predict that the two intact filaggrin repeats
encoded by the 3702delG allele identified here might not
be processed into any filaggrin at all. The R501X and
2282del4 alleles have been shown biochemically to produce
no detectable processed filaggrin, the end product of the FLG
gene, and can therefore be regarded as functional null alleles,
despite the synthesis of a short N-terminal profilaggrin
peptide (Smith et al., 2006). It is unclear whether the novel
3702delG mutation seen here also acts as a null for processed
filaggrin as biopsy material from this pediatric patient was not
available for study. Identification of similar mutations in adult
IV patients may address this issue in the future.
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Filaggrin mutation analysis
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Figure 3. Molecular genetic analysis of ichthyosis vulgaris. (a) Schematic
diagram of the gene encoding filaggrin (FLG) showing protein domain
organization within the three exon gene structure. The extent of the specific
PCR used to identify the 3702delG mutation is shown above. The positions of
the three known filaggrin mutations are shown below. (b) Direct DNA
sequencing of specific FLG PCR products. Top panels show identification of
the novel 3702delG mutation in the proband of Family 1. Lower panels show
identification of the first 2282del4 homozygous mutation in Family 2. (c)
Fluorescent PCR analysis to confirm FLG deletion mutations. Short specific
PCR products were end-labelled with the 6-fluorescein phosphoramidite
fluorochrome and run on an ABI automated DNA sequencer for accurate sub-
base-pair sizing. Left panel shows analysis of a normal control (top) compared
to the proband of Family 1 (bottom), who carries the 3702delG mutation. The
right panel shows a normal control (top) compared to the proband in Family
2, who is homozygous for 2282del4 (bottom). By this method, the 3702delG
mutation was excluded from B400 ethnically matched controls.
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A dense cluster of tyrosine residues occurs at the extreme
C-terminus of both mouse and human profilaggrin. It is
tempting to speculate that this may be some form of
prominent tyrosine phosphorylation site involved in the
control of profilaggrin cleavage during the terminal differ-
entiation of the epidermis. Profilaggrin phosphatase has been
shown to be important for processing of profilaggrin (Kam
et al., 1993) and serine/threonine phosphorylation within the
filaggrin repeats has also been demonstrated (Resing et al.,
1995); however, profilaggrin regulation by phosphorylation is
an area that requires further study. Analysis of further rare
filaggrin mutations, in parallel with biochemical studies, may
shed light on the temporally controlled processing of this
complex polyprotein system during terminal differentiation of
the epidermis.
We have recently demonstrated in nine extended IV
families that AD co-segregates with loss-of-function filaggrin
mutations as a second lower penetrance trait in addition to
the high penetrance IV phenotype (Palmer et al., 2006).
Genetic linkage between AD and FLG mutations in those
nine kindreds gave a statistically significant two-point lod
score of Zmax¼ 3.27, which remained significant when
artificially low penetrance values and/or phenocopy model-
ling were applied (Palmer et al., 2006). The association
between AD and the FLG null variants was further confirmed
in two independent association studies and one prospective
study, all of which have extremely significant w2 P-values and
odds ratios (Palmer et al., 2006). Consistent with the reported
association, AD featured in the IV kindreds analyzed here
(Figure 2). Specifically, 4/12 confirmed or inferred hetero-
zygotes and 7/7 homozygous filaggrin null individuals, where
examination was possible, had dermatologist-verified AD.
Adding the FLG-AD linkage data from the families here to
those previously reported (Palmer et al., 2006) brings the
cumulative two-point lod score for AD to Zmax¼3.96 at
y¼0. This with the strong evidence from association studies
(Palmer et al., 2006), which gave w2 P-values down to
31017 (Irish pediatric AD cohort), adds further strength to
the case for filaggrin deficiency being a strong transmissible
predisposing factor in AD.
Our studies on filaggrin mutations firmly establish a
prominent role for an epidermal barrier defect in both IV
and AD and represent a good example where the study of a
single-gene Mendelian disorder can shed a great deal of light
on a related complex trait, as suggested previously (Irvine and
McLean, 2003; Antonarakis and Beckmann, 2006).
MATERIALS AND METHODS
Clinical material
Blood and/or saliva samples were obtained from six Irish families with
IV and normal ethnically matched controls. Patients gave written
informed consent that complies with all the Declaration of Helsinki
Principles. The Research Ethics Committee of the Our Lady’s
Children’s Hospital, Crumlin, Dublin, approved all described studies.
R501X mutation analysis
Mutation R501X creates a new NlaIII restriction enzyme site, which
was used to screen the mutation from affected and unaffected family
members and from control samples, as described previously (Smith
et al., 2006). Genotyping for R501X was also performed using a
TAQMAN-based allelic discrimination assay (Palmer et al., 2006).
2282del4 mutation analysis
A PCR fragment amplifying 811 bp of genomic DNA was amplified
with forward primer RPT1P7 and reverse primer RPT2P1 (Smith
et al., 2006). Mutation 2282del4 creates a new DraIII restriction
enzyme site, which was used to screen samples for this mutation.
This mutation, 2282del4, was also genotyped by sizing of a
fluorescent-labelled PCR fragment on an Applied Biosystems 3100
or 3730 DNA sequencer (Palmer et al., 2006).
3702delG mutation analysis
A PCR fragment of 3697 bp was amplified from human genomic
DNA using forward primer FILF3 (50-GCT GAT AAT GTG ATT CTG
TCT G-30) and reverse primer RPT3P10R (50-GAC CCC GAT GAT
TGT TCC TGT-30). This PCR fragment encompasses the 50-end of
exon 3 of the profilaggrin gene, repeats 1 and 2 and 401 bp of repeat
3. PCR conditions were as follows: (941C 5 minutes)  1; (941C
30 seconds, 611C 45 seconds, 721C 3 minutes 20 seconds)  31
cycles; and a final extension at 721C for 5 minutes. The 3697 bp PCR
fragment was sequenced with primers FILr3.F1 (50-GGG TCA GGA
CAC CAT TCG TGC-30) and RPT3P10R.
The 3702delG mutation was confirmed by cloning of a genomic
PCR product into the TA cloning vector (Invitrogen, Paisley, UK) and
sequencing of several recombinant clones. Forward primer FILr3.F1
and reverse primer RPT3P10R were used to amplify a 300 bp PCR
fragment. Specific PCR conditions were as follows: (941C 5 minutes)
 1; (941C 30 seconds, 601C 30 seconds, 721C 1 minute)  34
cycles; and a final extension at 721C for 5 minutes. The PCR product
was ligated overnight at 141C into pCR2.1 vector and transformed
into competent TOP10 cells according to the manufacturer’s
protocol (Invitrogen).
Mutation 3702delG was screened by sizing of a fluorescent-
labelled PCR fragment on an Applied Biosystems 3100 or 3730 DNA
sequencer. Ten microliters PCR reactions were carried out using
forward primer 3702DELG.F1 (50-GCA AGC AGA CAA ACT CGT
AAG-30) and reverse primer 3702DELG.R2 (50-GTT TCT TCA GAC
AAC CTC TCG GAG TCG-30) in AmpliTaq Gold buffer containing
1.5 mM MgCl2 (Applied Biosystems, Foster City, CA), 10 nmol of
each deoxynucleoside triphosphate, and 0.5 U AmpliTaq Gold DNA
polymerase. Forward primer 3702DELG.F1 was labelled at the 50-
end with the 6-fluorescein phosphoramidite (6-FAM) fluorochrome.
Reactions were amplified as follows: (941C 12 minutes)  1; (941C
30 seconds, 631C 30 seconds, 721C 45 seconds)  31; and (721C
5 minutes)  1. PCR fragments were diluted 1:60 and sized against
ROX-500 size markers according to the manufacturer’s recom-
mended protocol (Applied Biosystems). The wild-type allele gave a
peak at 224 bp, whereas the 3702delG allele gave a 223 bp peak.
Genetic linkage analysis
Lod scores were calculated with MLINK algorithm of LINKAGE
version 5.1, using a semidominant model of the disease with a low
penetrance value of 45%. Penetrance was estimated from previous
studies of pediatric AD/asthma cohorts (Palmer et al., 2006) and
therefore represents a realistic but conservative approximation. The
combined mutant allele frequency was assumed to be 0.045, as
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previously determined in European populations (Palmer et al., 2006).
Although the 3702delG mutation is present at a negligible allele
frequency in the general population, when combined with the two
prevalent mutant alleles, the overall lod score was not appreciably
altered.
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